I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD16-positive, CD56-dim natural killer cell, human | 7 studies | 23% ± 5% | |
| classical monocyte | 6 studies | 23% ± 6% | |
| regulatory T cell | 6 studies | 18% ± 3% | |
| natural killer cell | 6 studies | 19% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 22% ± 5% | |
| CD4-positive, alpha-beta T cell | 5 studies | 18% ± 2% | |
| CD8-positive, alpha-beta T cell | 5 studies | 21% ± 5% | |
| epithelial cell | 5 studies | 26% ± 10% | |
| naive B cell | 5 studies | 20% ± 3% | |
| gamma-delta T cell | 5 studies | 21% ± 8% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 22% ± 3% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 21% ± 4% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| T follicular helper cell | 3 studies | 16% ± 1% | |
| memory B cell | 3 studies | 19% ± 4% | |
| GABAergic neuron | 3 studies | 24% ± 5% | |
| glutamatergic neuron | 3 studies | 26% ± 6% | |
| CD8-positive, alpha-beta memory T cell | 3 studies | 21% ± 4% |
